Masimo Corp. (MASI) announced on Wednesday that Michelle Brennan, a current board member, will serve as interim CEO following the resignation of Chairman and CEO Joe Kiani.
Additionally, Masimo confirmed its non-GAAP financial guidance for the third quarter of 2024, which was previously shared on August 6, 2024.
Currently, shares are gaining more than 6 percent in the pre-market session.
Brennan joined the Board in 2023 and has over 30 years of experience as a senior executive at Johnson & Johnson, where she managed global medical device and consumer pharmaceutical businesses.
The company has hired the search firm Korn Ferry to aid in the process of finding a new CEO.
Currently, MASI's stock is trading at $133.84, up 6.09% on the Nasdaq.
For comments and feedback: editorial@rttnews.com